Vijaya Diagnostic Centre to attend EMKAY Confluence 2026 investor meet
NiveshIQ
NSE: VIJAYA · Healthcare
Vijaya Diagnostic Centre Ltd.
₹1,372.00▲ ₹12.90 (+0.95%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on VIJAYA. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Vijaya Diagnostic Centre Ltd.
Vijaya Diagnostic Centre Limited is a leading diagnostic services provider in India, offering a comprehensive range of laboratory services, including clinical pathology, microbiology, and imaging services. The company has a strong presence in the Indian healthcare market, with a revenue of ₹768 Cr and a net income of ₹159 Cr. Vijaya Diagnostic Centre Limited has delivered robust growth, with a 26.6% revenue growth in Q4 FY 2026, led by volume and expansion. The company's EBITDA margin has expanded to 43.5%, driven by AI-led diagnostic growth. With a strong competitive position and growth outlook, Vijaya Diagnostic Centre Limited is well-positioned to capitalize on the growing demand for diagnostic services in India. The company has a buy rating from analysts, with a target price of ₹1222.
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹548.00 Cr +134.20% | ₹681.00 Cr +24.30% | ₹814.20 Cr +19.60% |
| EBITDA Margin | 40.15% | 40.09% | 43.94% |
| Net Profit | ₹120.00 Cr +172.70% | ₹144.00 Cr +20.00% | ₹172.98 Cr +20.10% |
| EPS | ₹11.63 | ₹13.97 | ₹16.81 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Vijaya Diagnostic Centre Q1 Results: Earnings call scheduled for Aug 7
Vijaya Diagnostic Centre Ltd is Rated Buy
🔒
+ 3 more stories about Vijaya Diagnostic Centre Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹219 Cr, PAT ₹48 Cr, EPS ₹4.66, EBITDA margin 44.6%. Growth context: revenue YoY +26.8%, PAT YoY +36.9%, revenue QoQ +7.0%, PAT QoQ +11.5%. Street verdict: beat, revenue surprise +1.4%, PAT surprise +0.6%.
Management commentary points to new capacity addition and capex deployment as the primary near-term growth lever, with e...
Forward consensus estimates for the next FY will be the key financial watchpoint as the current year plays out....
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for VIJAYA
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track VIJAYA alongside your other holdings
Unlock full VIJAYA research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Vijaya Diagnostic Centre Ltd.?
NiveshIQ detects active intelligence signals for Vijaya Diagnostic Centre Ltd. (VIJAYA) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Vijaya Diagnostic Centre Ltd.?
Vijaya Diagnostic Centre Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,311,933.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.